Eli Lilly and Company (NYSE:LLY) Stock Price Down 0.7% Following Analyst Downgrade
Shares of Eli Lilly and Company (NYSE:LLY – Get Free Report) were down 0.7% during mid-day trading on Friday after Barclays lowered their price target on the stock from $1,025.00 to $975.00. Barclays ...
$35 insulin: Who in the US benefits?
Vice President Kamala Harris on the campaign trail has frequently touted capping the price of insulin at $35 a month as a ...
ADOCIA Reports Third Quarter 2024 Financial Results and Provides a Business Update
Adocia (Euronext Paris: FR0011184241 – ADOC, the "Company"), a clinical-stage biopharmaceutical company focused on the ...
Eli Lilly and Company (NYSE:LLY) Shares Sold by Hunter Associates Investment Management LLC
Hunter Associates Investment Management LLC trimmed its position in Eli Lilly and Company (NYSE:LLY – Free Report) by 0.8% in ...
Explainer-Who in the US Benefits From $35 Insulin?
Nearly one-third of those patients were paying $35 or far more per month in 2019, according to the latest available data from ...
Diabetes patients worry about insulin shortages as Ozempic use skyrockets
The insulin is facing supply shortages as diabetes patients increasingly turn to GLP-1 weight loss drugs such as Ozempic and ...
Hosted on MSN7mon
Eli Lilly warns of shortage of insulin products
Drugmaker Eli Lilly & Co is announcing a temporary shortage of two of its insulin products. "The 10 mL [millilter] vials of Humalog® and Insulin Lispro Injection are or will be temporarily out of ...
Hosted on MSN7mon
Eli Lilly warns 2 of its insulin products may be out of stock
The company said it's experiencing a shortage of its 10 mL vials of Humalog and Insulin Lispro Injection medications. Eli Lilly said the medications are or will be "temporarily out of stock at ...